Recombinant Vaccines Market Updates : Projected to Surpass USD 24.7 Billion by 2031, a CAGR of 11.4% from 2022 to 2031
The recombinant vaccines market was valued at $8.1 billion in 2021, and estimated to reach $24.7 billion by 2031, growing at a CAGR of 11.4% from 2022 to 2031. WILMINGTON, DELAWARE , UNITED STATES, April 15, 2024 /EINPresswire.com/ -- According …